Committees

Hearings and Testimony

Legislative History

Legislative Update

Hot Topics and More Information

How To Reach Us

Back To

Home Page
A rundown of Congressional Hearings of Interest
Hearings and Testimony
Recent Testimony
Cancer Research | Appropriations

CANCER RESEARCHCOMMITTEE DATE TESTIMONY
  The House Energy and Commerce Subcommittee on Health 6/2/04 Scientific Opportunities and Public Needs: Balancing NIH's Priority Setting Process
Dr. Andrew C. von Eschenbach, Director, National Cancer Institute, testified.
The witness provided oral testimony and NCI was not asked to provide a written statement at the hearing. Therefore no written testimony is available for this hearing.
  The House Energy and Commerce Subcommittee on Oversight and Investigations 5/18/04 NIH Ethics Concerns: Consulting Arrangements and Outside Awards
The NCI witnesses at this hearing were Dr. Lance A. Liotta, Chief of the Laboratory of Pathology; Dr. J. Carl Barrett, Director, Center for Cancer Research; and Dr. Anna D. Barker, Deputy Director for Advanced Technologies & Strategic Partnerships.
The witnesses provided oral testimony and NCI was not asked to provide written statements at either hearing. Therefore no written testimony is available for these hearings.
  House Committee on Government Reform, Subcommittee on Wellness and Human Rights 5/13/04 Delivering More Innovative and Effective Treatments to Make Cancer a More Treatable Disease
Statement of Michaele Chamblee Christian, M.D., Associate Director, Division of Cancer Treatment and Diagnosis, Cancer Evaluation Therapy Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services
  House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy and Human Resources 3/11/04 National Cancer Institute Research on Human Papillomavirus and Cervical Cancer
Statement of Edward Trimble, M.P.H., Cancer Evaluation Therapy Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services
  House Committee on Government Reform, Subcommittee on Wellness and Human Rights 11/13/03 Statement of Robert N. Hoover, M.D., Sc.D.
Director, Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services
  House Committee on Government Reform, Subcommittee on Wellness and Human Rights 9/10/03 Research on SV 40 Exposure and the Development of Cancer
Statement of James Goedert, M.D., Chief, Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute
  House Committee on Energy and Commerce, Subcommittee on Health 7/10/03 NIH: Moving Research from the Bench to the Bedside
Statement of Anna D. Barker, Ph.D., Deputy Director for Strategic Scientific Initiatives, National Cancer Institute
  House Committee on Government Reform 6/3/03 The Science of Potential Reduced Risk Tobacco Products
Statement of Scott J. Leischow, Ph.D., Chief, Tobacco Control Research Branch, National Cancer Institute
  Senate Cancer Coalition 6/17/03 Research on Molecular Targets to Diagnose, Prevent and Treat Cancer
Statement of J. Carl Barrett, Ph.D., Director, Center for Cancer Research, National Cancer Institute
  Senate Cancer Coalition 3/31/03 Cancer Survivorship: Moving the Science and Art of Research and Care Beyond Cure
Statement of Julia H. Rowland, Ph.D., Director, Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute
  Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies and the Committee on Health, Education, Labor and Pensions, Subcommittee on Public Health 2/28/02 Mammography
Statement of Andrew von Eschenbach, M.D., Director, National Cancer Institute
  Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies 6/21/01 Leukemia, Lymphoma, and Multiple Myeloma: Toward a New Understanding
Richard Klausner, M.D., Director, National Cancer Institute
  Senate Committee on the Environment and Public Works 6/11/01 The Environment, Genes, and Cancer
Deborah Winn, Ph.D., Acting Associate Director, Epidemiology and Genetics Research Program, Division of Cancer Control and Prevention
  Senate Cancer Coalition 6/5/01 Role of the National Cancer Institute in Addressing Cancer Clusters
Robert Hoover, M.D., Sc.D., Director, Epidemiology and Biostatistics Program;Accompanied by
Susan Devesa, Ph.D., Chief, Descriptive Studies Section, Epidemiology and Biostatistics Program
  Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies 5/9/01 New Directions in Breast Cancer Research
Richard Klausner, M.D., Director, NCI
  House Committee on Government Reform 9/25/00 Ethnic Minority Disparities in Cancer Treatment: Why the Unequal Burden?
Harold Freeman, M.D., Director, Center to Reduce Cancer Health Disparities, NCI
  House Committee on Government Reform 6/7/00 Integrative Oncology: Cancer Care for the Next Millenium
Dr. Robert Wittes, Deputy Director of Extramural Science and Director, Division of Cancer Treatment and Diagnosis, NCI
  House Committee on Government Reform 9/23/99 Prostate Cancer Research at the National Cancer Institute
Richard Kaplan, M.D., Senior Investigator, Cancer Therapy Evaluation Program, NCI
  Senate Cancer Coalition 9/16/99 Cancer Care in The United States: What's Right, What's Wrong? Ensuring the Quality of Cancer Care
Robert Hiatt, M.D., Ph.D., Deputy Director of the Division of Cancer Control and Population Sciences
  Senate Appropriations Subcommittee on labor, Health and Human Services, Education and Related Agencies 6/16/99 Planning for Prostate Cancer Research: Expanding the Framework and Professional Judgment Estimates 
Richard D. Klausner, M.D., Director, National Cancer Institute, and Harold Varmus, M.D., Director, National Institutes of Health
  House Committee on Government Reform 6/10/99 The Role of Complementary and Alternative Medicine in the Detection and Treatment of Women's Cancers
Edward L. Trimble, Head, Surgery Section, Division of Cancer Treatment and Diagnosis
  Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies 1/21/99 The Unequal Burden of Cancer:   NCI Response to a Report by the Institute of Medicine
Richard Klausner, MD, Director, NCI
  Senate Committee on Governmental Affairs Permanent Subcommittee on Investigations 9/16/98 NCI Management of Radiation Studies
Richard Klausner, MD, Director, NCI
  House Government Reform and Oversight Committee 7/31/98 On the Status of the Integration of Complementary and Alternative Medicine (CAM) and Cancer
Richard Klausner, MD, Director, NCI
  Subcommittee on Health and Environment 7/20/98 The State of Cancer Research
Edison Liu, M.D., Director, Division of Clinical Sciences, accompanied by Dr. Steven Rosenberg, M.D., Ph.D., Chief of Surgery 
  Senate Cancer Coalition 7/16/98 Cancer Treatments for the 21st Century
Edison Liu, M.D., Director, Division of Clinical Sciences 
  Congressional Caucus for Women's Issues 4/30/98 Breast Cancer Prevention Trial
Leslie Ford, M.D. Associate Director for Early Detection and Community Oncology, NCI
  Senate Appropriations Subcommittee on Labor, HHS, & Related Agencies 4/21/98 Breast Cancer Prevention Trial
Richard Klausner, MD, Director, NCI
  Senate Appropriations Subcommittee on Labor, HHS, & Related Agencies 10/1/97 Estimated Exposures and Thyroid Doses Received by the American People from Iodine-131 in Fallout Following the Nevada Atmospheric Nuclear Bomb Tests
Richard Klausner, MD, Director, NCI
  Senate Appropriations Subcommittee on Labor, HHS, & Related Agencies 6/19/97 Progress Against Cancer
Richard Klausner, MD, Director, NCI
  Senate Appropriations Subcommittee on Labor, HHS, & Related Agencies 5/7/97 Advances in Cancer Research
  Senate Cancer Coalition 3/6/97 Environmental Risk Factors and Cancer
Susan Sieber, PhD, NCI
  Senate Appropriations Subcommittee on Labor, HHS, & Related Agencies 2/5/97 Mammography Screening for Women Ages 40-49
Richard Klausner, MD, Director, NCI
  Senate Cancer Coalition 6/13/96 Bone Marrow Transplantation for Breast Cancer
Jeffrey Abrams, MD, NCI
  Senate Committee on Labor & Human Resources 3/6/96 Cancer, Genetics, and the Environment
Francis Collins, MD, PhD, Director, NIHGR;
Richard Klausner, MD, Director, NCI; and
Kenneth Olden, PhD, Director, NIEHS
APPROPRIATIONSCOMMITTEEDATETESTIMONY
 Senate Subcommittee on Labor-HHS-Education Appropriations4/1/04Fiscal Year 2005 Budget Request
Andrew C. von Eschenbach, M.D., Director, National Cancer Institute; William Beldon, Acting Deputy Assistant Secretary, Budget
  Senate Subcommittee on Labor-HHS-Education Appropriations 4/8/03 Fiscal Year 2004 Budget Request
Andrew C. von Eschenbach, M.D., Director, National Cancer Institute; Willam R. Beldon, Acting Deputy Assistance Secretary for Budget, DHHS; Kerry N. Weems, Acting Assistant Secretary for Budget, Technology and Finance
  House Appropriations Subcommittee on Labor-HHS-Education 3/13/02 Fiscal Year 2003 Budget Request
Andrew C. von Eschenbach, M.D., Director, National Cancer Institute;
Kerry N. Weems, Acting Deputy Assistant Secretary for Budget, Department of Health and Human Services
Senate Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies 5/23/01 Statement of the NCI Director for Fiscal Year 2002 President's Budget Request
Richard Klausner, MD, Director, NCI
House Subcommittee on Labor-HHS-Education Appropriations 5/16/01 Statement of the NCI Director on the Fiscal Year 2002 President's Budget Request
Richard Klausner, MD, Director, NCI
Senate Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies 3/30/00 Statement of the NCI Director for Fiscal Year 2001
Richard Klausner, MD, Director, NCI
House Appropriations Subcommittee on Labor, Health and Human Services, and Education 2/15/00 Statement of the NCI Director for Fiscal Year 2001
Richard Klausner, MD, Director, NCI
  House Appropriations Subcommittee on Labor, Health and Human Services, and Education 2/24/99 Statement of the NCI Director for Fiscal Year 2000
Richard Klausner, MD, Director, NCI
  Senate Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies 2/23/99 Statement of the NCI Director for Fiscal Year 2000
Richard Klausner, MD, Director, NCI
  House & Senate Appropriations Subcommittees on Labor, HHS, & Related Agencies 3/25/98 Statement of the NCI Director for Fiscal Year 1999
Richard Klausner, MD, Director, NCI
  House & Senate Appropriations Subcommittees on Labor, HHS, & Related Agencies 2/97 Statement of the NCI Director for Fiscal Year 1998
Richard Klausner, MD, Director, NCI

Committees | Hearings and Testimony | Legislative History | Legislative Update
| Hot Topics and More Information | How to Reach Us


National Cancer Institute Home Page  

This site is provided as an informational service for advisory committee members, patient groups, members of the public, and employees, and does not constitute the endorsement of the NCI, NIH, or DHHS of any legislative proposal. No inference should be drawn from the coverage or lack of coverage of any pending legislation herein.